CJ, AF, LJ, HH, CK, and LN performed the data analysis, wrote, and revised the manuscript
Q&A with John Bothmer, Clinical Translation Medicine Fellow at Angelini Pharma To further explore the scientific, regulatory and operational complexity behind FirstinHuman trials , we spoke with John Bothmer, Clinical Translation Medicine Fellow within the Global Clinical Development & Clinical Operations department at Angelini Pharma , about the role these studies play in clinical development and the safeguards that support this transition from preclinical research to human investigation
A dual-layer ampoule mist that combines a nourishing cream layer with a hydrating ampoule layer to deliver instant moisture, brightening, and elasticity care in a single spray
282(2):E474-82
The treatment implications differ based on which mechanism is responsible
Protective effects and mechanisms of action of methyl-GBB in the preclinical models of diabetes and its complications